NKGen Biotech Inc NKGN shares are trading higher by 25% to $1.17 Thursday morning after the company announced it will present new SNK01 biomarker data at the Alzheimer’s Association International Conference.
NKGen Biotech says the data will be presented at the conference in Philadelphia and online from July 28 to August 1, 2024. The data shows SNK01’s ability to reduce α-synuclein, linked to cognitive decline in Alzheimer’s patients.
The presentation by Dr. Paul Y. Song will take place on July 30, 2024. Additional details and a copy of the poster will be available on NKGen’s website. The company says previous Phase 1 data on SNK01’s effects on other Alzheimer’s biomarkers are also available on their website.
Read Also: Apple, Nvidia Supplier TSMC Stock Rises In Thursday’s Premarket After Crashing 8% In Last Session
How To Buy NKGN Stock
By now you're likely curious about how to participate in the market for NKGen Biotech – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of NKGen Biotech, which is trading at $0.94 as of publishing time, $100 would buy you 106.38 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
NKGN has a 52-week high of $6.70 and a 52-week low of $0.78.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
